Thongprasert, S., Geater, S. L., Clement, D., Abdelaziz, A., Reyes-Igama, J., Jovanovic, D., . . . Gaafar, R. (2019). Afatinib in locally advanced/metastatic NSCLC harboring common EGFR mutations, after chemotherapy: A Phase IV study. Lung Cancer Manag.
Citação norma ChicagoThongprasert, Sumitra, et al. "Afatinib in Locally Advanced/metastatic NSCLC Harboring Common EGFR Mutations, After Chemotherapy: A Phase IV Study." Lung Cancer Manag 2019.
MLA CitationThongprasert, Sumitra, et al. "Afatinib in Locally Advanced/metastatic NSCLC Harboring Common EGFR Mutations, After Chemotherapy: A Phase IV Study." Lung Cancer Manag 2019.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.